Nanoparticle Albumin-Bound Rapamycin
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Nanoparticle Albumin-Bound Rapamycin, covering 2023-03-30 to 2023-03-30. Get the full timeline:
Most recent: Clinical Trial Update: Nanoparticle Albumin-Bound Rapamycin, Temozolomide, and Irinotecan Hydrochloride in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors [Phase 1]